Skip to main content
Taiho Oncology Patient Support™ supporting your treatment journey
FAQ
 
1-844-TAIHO-4U  (1-844-824-4648)
  • Download in English
  • Download in Spanish

For Healthcare Professionals Only

Mobile navigation before

  • Download Enrollment Form
    • Download in English
    • Download in Spanish

Main navigation

  • Welcome
  • Financial Support
  • How to Enroll
  • Products and Resources
    • INQOVI®
      (decitabine and cedazuridine)
      35mg/100mg tablets
    • LONSURF®
      (trifluridine and tipiracil) tablets
    • LYTGOBI®
      (futibatinib) tablets

Mobile navigation after

  • FAQ
  • Contact Us
  • Privacy Policy
  • Terms of Use

Contact Us

Taiho Oncology Patient Support 

If you have questions, call 1‑844‑TAIHO‑4U (1‑844‑824‑4648)

Taiho Oncology

Footer

  • Privacy Policy
  • Terms of Use
  • Contact Us

Use of this Site is subject to the Internet Site Legal Notices and Disclaimers and Privacy Policy. This Site is intended for U.S. audiences only. Products discussed herein may have different labeling in different countries.
LONSURF® is a registered trademark of TAIHO PHARMACEUTICAL CO. LTD. and used under license.
Developed by © Astex Pharmaceuticals, Inc. Marketed by © Taiho Oncology, Inc. INQOVI® is a registered trademark of Otsuka Pharmaceutical Co., Ltd.
LYTGOBI® is a registered trademark of Taiho Pharmaceutical Co., Ltd. 
Copyright © TAIHO ONCOLOGY, INC. 2026. All rights reserved. [04/26] TOI-PM-US-0252 v13